LACMED (5341.KL) stock: key figures, P/E, revenue and dividend

Health Care · Malaysia

Price
0.67 MYR
Market cap
266.00 m MYR
P/E (2025)
12.13
P/S (2025)
1.32
Dividend yield
0.98 %
Net margin
10.88 %
Return on equity (ROE)
18.47 %
Return on assets (ROA)
9.29 %

LACMED financials

Fiscal year20242025
Revenue183.22 m MYR201.63 m MYR
Gross profit45.48 m MYR58.48 m MYR
Operating income27.61 m MYR31.47 m MYR
EBIT27.54 m MYR31.63 m MYR
Net income20.40 m MYR21.94 m MYR
Diluted EPS – continuing operations0.05 MYR0.05 MYR

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About LACMED

LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Malaysia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.